MedPath

Parangipattai Rasayanam in the management of kaalaanjagappadai(psoriasis)

Phase 3
Completed
Conditions
KALANJAGAPADAI (PSORIASIS)
Registration Number
CTRI/2018/02/011904
Lead Sponsor
NATIONAL INSTITUTE OF SIDDHA TAMBARAM SANATORIUM CHENNAI
Brief Summary

Is is a single, non-randomized, open label trial to determine the efficacy and safety of Parangipattai Rasayanam in patients with kalanjagapadai.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Erythema Thickness Scaling Ithching :with or without itching Auspitz sign + Candle crease sign + • Age : 20-60 years • Sex : Both male and female • Willing to give specimen of blood for the investigation whenever required.
  • • Willing to participate in trial and signing consent by fulfiling the condition of proforma.
Exclusion Criteria

Hypertension Diabetes mellitus Cardiac disease Use of narcotic drugs Pregnancy and lactation Psoriasis with evidence of any other skin disease Psoriatic arthropathy Evidences of secondary infection in the lesions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
GOOD OUTCOME- CLEARANCE OF LESIONS AND REDUCTION OF PASI SCORE FROM 3,4 TO 0,1.40 DAYS
MODERATE OUTCOME- CLEARANCE OF LESIONS AND REDUCTION OF PASI SCORE FROM 3,4 TO 1,2.40 DAYS
POOR OUTCOME- NO40 DAYS
CLEARANCE OF LESIONS OR NO REDUCTION OF PASI SCORE.40 DAYS
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NATIONAL INSTITUTE OF SIDDHA

🇮🇳

Kancheepuram, TAMIL NADU, India

NATIONAL INSTITUTE OF SIDDHA
🇮🇳Kancheepuram, TAMIL NADU, India
Dr V MAHALAKSHMI
Principal investigator
9444519975
rvmahalakshmi85@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.